| Product Code: ETC13369945 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Vaccine Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Vaccine Market - Industry Life Cycle |
3.4 Europe Vaccine Market - Porter's Five Forces |
3.5 Europe Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Europe Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Europe Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Europe Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Europe Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Vaccine Market Trends |
6 Europe Vaccine Market, 2021 - 2031 |
6.1 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Europe Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Europe Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Europe Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Europe Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Europe Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Europe Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Europe Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Europe Vaccine Market, Revenues & Volume, By Oral, 2020 - 2028 |
6.5 Europe Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Vaccine Market, Revenues & Volume, By mRNAbased, 2020 - 2028 |
6.5.3 Europe Vaccine Market, Revenues & Volume, By Viral Vector, 2020 - 2028 |
6.5.4 Europe Vaccine Market, Revenues & Volume, By Protein Subunit, 2020 - 2028 |
7 Europe Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
7.3.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.2 Germany Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.3 France Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.4 Poland Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.5 Spain Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.6 Rest of Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 Germany Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 France Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Poland Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.5 Spain Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.6 Rest of Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Germany Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 France Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Poland Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.5 Spain Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.6 Rest of Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Germany Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 France Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Poland Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.5 Spain Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.6 Rest of Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Europe Vaccine Market Key Performance Indicators |
9 Europe Vaccine Market - Export/Import By Countries Assessment |
10 Europe Vaccine Market - Opportunity Assessment |
10.1 Europe Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.4 Europe Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Europe Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Europe Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Europe Vaccine Market - Competitive Landscape |
11.1 Europe Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Europe Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here